EUVIMEDEUVIMED entdecken
Crossref

Development of a Cascade-Targeting Oral Vaccine via Glycoprotein 2 on Intestinal Microfold Cells for Cancer Immunotherapy

Wanqiong Li, Xin Yang, Mengfan Wang, Zheng Hu, Shaomeng Chen, Xinghua Sui, Danhong Chen, Xiaoshuang Niu, Juan Liu, Youmei Xiao iD, Xiuman Zhou, Guanyu Chen und 1 weitere

Nano Letters · 02.04.2025 · 25 (13) · 5165-5173

DOI: 10.1021/acs.nanolett.4c06123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, online erschienen am 24.02.2025. Verfasst von Wanqiong Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Shenzhen Medical Research Fund, The Guangdong Basic and Applied Basic Research Foundation, The Fundamental Research Funds for the Central Universities, Sun Yat-sen University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral cancer vaccines are convenient and safe, with the presence of gut-associated lymphoid tissue (GALT) involved intestinal Peyer's patch (PPs) containing microfold (M) cells and housing abundant underneath dendritic cells (DCs). Here, we found that the endocytic receptors glycoprotein 2 (GP2) and dectin-1 are respectively expressed on M cells and DCs with high specificity. Then, we discovered a gastrointestinal hydrolysis-resistant D-peptide DGPBP-2(1-8) targeting GP2 by phage display screening and optimization. DGPBP-2(1-8) was conjugated to β-glucan (dectin-1 ligand)-containing yeast capsules (GP2-YCs) to design a cascade-targeting oral vaccine platform, which can help the antigen to efficiently cross intestinal M cells and subsequently be endocytosed by underneath DCs, thus activating CD8+ T cells. More importantly, this oral vaccine can evoke not only cellular but also humoral and mucosal immune responses. Therefore, this cascade-targeting oral vaccine could serve as a novel platform for cancer immunotherapy and infectious disease prevention as well.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesImmunotherapyNeoplasmsAnimalsAdministration, OralMiceDendritic CellsHumansPeyer's PatchesLectins, C-TypeCD8-Positive T-LymphocytesMice, Inbred C57BLM CellsDectin-1

Stichwörter der Autor:innen

cancer immunotherapyglycoprotein 2intestinal microfold celloral vaccinepeptide

Substanzen

Cancer VaccinesLectins, C-TypeDectin-1

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.

ORCID-Profile: Youmei Xiao, Yanfeng Gao

Förderung

  • Shenzhen Medical Research Fund
  • The Guangdong Basic and Applied Basic Research Foundation
  • The Fundamental Research Funds for the Central Universities, Sun Yat-sen University
  • The Postdoctoral Fellowship Program of CPSF
  • The National Natural Science Foundation of China
  • The "Pearl River Talent Plan" Innovation and Entrepreneurship Team Project of Guangdong Province

Zitieren

APA

Li, W., Yang, X., Wang, M., Hu, Z., Chen, S., Sui, X., Chen, D., Niu, X., Liu, J., Xiao, Y., Zhou, X., Chen, G., & Gao, Y. (2025). Development of a Cascade-Targeting Oral Vaccine via Glycoprotein 2 on Intestinal Microfold Cells for Cancer Immunotherapy. Nano Letters, 25(13), 5165-5173. https://doi.org/10.1021/acs.nanolett.4c06123

Vancouver

Li W, Yang X, Wang M, Hu Z, Chen S, Sui X, et al. Development of a Cascade-Targeting Oral Vaccine via Glycoprotein 2 on Intestinal Microfold Cells for Cancer Immunotherapy. Nano Letters. 2025;25(13):5165-5173. doi:10.1021/acs.nanolett.4c06123

BibTeX
@article{Li2025,
  author = {Li, Wanqiong and Yang, Xin and Wang, Mengfan and Hu, Zheng and Chen, Shaomeng and Sui, Xinghua and Chen, Danhong and Niu, Xiaoshuang and Liu, Juan and Xiao, Youmei and Zhou, Xiuman and Chen, Guanyu and Gao, Yanfeng},
  title = {Development of a Cascade-Targeting Oral Vaccine via Glycoprotein 2 on Intestinal Microfold Cells for Cancer Immunotherapy},
  journal = {Nano Letters},
  year = {2025},
  volume = {25},
  number = {13},
  pages = {5165--5173},
  doi = {10.1021/acs.nanolett.4c06123}
}
Kostenlos starten →